Risk and management of bleeding complications with direct oral anticoagulants in patients with atrial fibrillation and venous thromboembolism: a narrative review

S Ballestri, E Romagnoli, D Arioli, V Coluccio… - Advances in …, 2023 - Springer
Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent conditions
with a significant healthcare burden, and represent the main indications for anticoagulation …

2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …

Writing Committee Members, JA Joglar… - Journal of the American …, 2024 - jacc.org
Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) …

AM Veitch, F Radaelli, R Alikhan, JM Dumonceau… - …, 2021 - thieme-connect.com
This is a collaboration between the British Society of Gastroenterology (BSG) and the
European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their …

Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

K Triantafyllou, P Gkolfakis, IM Gralnek, K Oakland… - …, 2021 - thieme-connect.com
1 ESGE recommends that the initial assessment of patients presenting with acute lower
gastrointestinal bleeding should include: a history of co-morbidities and medications that …

Management of patients with acute lower gastrointestinal bleeding: an updated ACG guideline

N Sengupta, JD Feuerstein, V Jairath… - Official journal of the …, 2023 - journals.lww.com
Acute lower gastrointestinal bleeding (LGIB) is a common reason for hospitalization in the
United States and is associated with significant utilization of hospital resources, as well as …

[HTML][HTML] Direct Oral anticoagulants in special patient populations

A Kessler, Y Kolben, G Puris, M Ellis, M Alperin… - Journal of Clinical …, 2023 - mdpi.com
Anticoagulants are a cornerstone of treatment in atrial fibrillation. Nowadays, direct oral
anticoagulants (DOACs) are extensively used for this condition in developed countries …

[HTML][HTML] 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …

WC Members, JA Joglar, MK Chung… - Journal of the American …, 2024 - Elsevier
Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

[HTML][HTML] Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC …

M Candeloro, N van Es, N Cantor, S Schulman… - Journal of Thrombosis …, 2021 - Elsevier
Background Gastrointestinal bleeding frequently complicates anticoagulant therapy causing
treatment discontinuation. Data to guide the decision regarding whether and when to …

[PDF][PDF] Consensus document of the Spanish Society of Digestives Diseases and the Spanish Society of Thrombosis and Haemostasis on massive nonvariceal …

FC Álvarez, AA Martínez, PL Silero, AO Calzada… - Rev Esp Enferm …, 2022 - online.reed.es
Introduction: there is limited experience and understanding of massive nonvariceal
gastrointestinal bleeding during therapy with direct-acting oral anticoagulants. Objectives: to …

Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data

W Hu, H Cai, J Zhang - European Journal of Clinical Pharmacology, 2022 - Springer
Purpose The objective of present study was to compare the safety and efficacy of resuming
direct-acting oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with …